Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports the construction of nitrogen-containing heterocycles, which are common in drugs targeting cancer and inflammatory diseases. The hydroxymethyl group allows for further functionalization, enabling attachment to other molecular fragments in drug design. Also employed in medicinal chemistry research for scaffold modification and optimization of pharmacokinetic properties.